ZYDUSLIFE logo

Zydus Lifesciences LTD

F&O
ZYDUSLIFE·NSE·
1,162.00 +0.70 (+0.06%)
Market Cap117512.55 Cr
PE Ratio23.20
Volume10,65,190
Day High - Low1183.00 - 1152.00
52W High-Low1205.00 - 835.50
DocStoX Score
6.9/10
Fair
Fair Value
Sign in to see
ROE
21.20%
Strong
P/E
23.20x
Fair
Debt / Equity
0.31
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

NIFTY NEXT 50NIFTY 100NIFTY 200
Day1152
1183
52W835.50
1205
DocStoX take

Supported by risk (8.8) and growth (7.9), but held back by valuation (3.3).

DocStoX score

Low confidence
6.9
/10
Fair
Quality
Solid
ROE 21.2%
Valuation
Rich
P/E 23.2×
Growth
Strong
Revenue +12.4% 5Y CAGR
Risk
Low risk
D/E 0.31
Momentum
Strong
88% of 52-week range

At a glance

Market Cap
₹1.18L Cr
52W High / Low
₹1205 / ₹836
Dividend Yield
0.08%
Promoter Holding
75.01%
EPS (TTM)
₹50.09
Book Value
₹269.00

Key highlights

  • Profitable in all of the last 5 years
  • Strong returns on equity (21%)
  • Capital works hard — ROCE 21%
4 Positives0 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ZYDUS LIFESCIENCES LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.